Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Cancer 8, 906–907 (1 December 2008) | doi:10.1038/nrc2551
Signalling: Making more of a mark
Abstract
Melanomas are resistant to many standard therapies and often metastasize, prompting an intensive search for novel therapeutic targets. A recent study has highlighted a role for Notch signalling in melanoma development under hypoxic conditions.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
